Stress-related mucosal disease in the critically ill patient

被引:0
|
作者
Marc Bardou
Jean-Pierre Quenot
Alan Barkun
机构
[1] CHU de Dijon,Gastroenterology and Hepatology Department
[2] France,Gastroenterology Department
[3] Medical Intensive Care Unit,undefined
[4] CHU de Dijon,undefined
[5] France,undefined
[6] McGill University Health Centre,undefined
[7] Montreal General Hospital Site,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Prevalence of clinically important stress-ulcer bleeding is low (∼1%), but because of its severity it remains an important issueProphylaxis for stress-ulcer bleeding should be restricted to patients with acknowledged risk factors because of the risk of nosocomial infectionDespite controversies, PPIs seem to be the most clinically effective and cost-effective strategyRandomized clinical trials and observational studies are needed to assess new preventive strategies and to adapt therapeutic management approaches of upper gastrointestinal bleeding to the intensive care unit settingStress-ulcer prophylaxis is being overused; two-thirds of patients without risk-factors receive treatment, two-thirds continue treatment upon transfer from the intensive care unit and one-third are discharged home on treatment without a new indication
引用
收藏
页码:98 / 107
页数:9
相关论文
共 50 条
  • [11] STRESS-RELATED MUCOSAL DISEASE - PATHOPHYSIOLOGY, PREVENTION, AND TREATMENT
    FISHER, RL
    PIPKIN, GA
    WOOD, JR
    CRITICAL CARE CLINICS, 1995, 11 (02) : 323 - 345
  • [12] STRESS-RELATED MUCOSAL DAMAGE
    PEURA, DA
    CLINICAL THERAPEUTICS, 1986, 8 : 14 - 23
  • [13] Intermittent intravenous pantoprazole and continuous cimetidine infusion: Effect on gastric pH control in critically ill patients at risk of developing stress-related mucosal disease
    Somberg, Lewis
    Morris, John, Jr.
    Fantus, Richard
    Graepel, Jay
    Field, Brian G.
    Lynn, Richard
    Karlstadt, Rokyn
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2008, 64 (05): : 1202 - 1210
  • [14] Stress-related mucosal disease: Risk factors and prophylactic therapy
    Spirt, MJ
    CLINICAL THERAPEUTICS, 2004, 26 (02) : 197 - 213
  • [15] Stress-related mucosal disease: Considerations of current medication prophylaxis
    Wirth, Scott M.
    Macaulay, Tracy E.
    Winstead, P. Shane
    Smith, Kelly M.
    ORTHOPEDICS, 2007, 30 (12) : 1010 - 1014
  • [16] Mitigating endoplasmic reticulum stress with revaprazan ameliorates stress-related mucosal disease
    Kim, Jung Ho
    Kim, Eun Hee
    Ock, Chanyoung
    Hong, Hua
    Kim, Yoon Jae
    Kwon, Kwang An
    Park, Dong Kyun
    Hahm, Ki Baik
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (01) : 120 - 129
  • [17] SUCRALFATE SUSPENSION VS ANTACIDS FOR THE PROPHYLAXIS OF STRESS-RELATED BLEEDING IN CRITICALLY ILL PATIENTS
    BRESALIER, RS
    GRENDELL, JH
    MEYER, AA
    CELLO, JP
    GASTROENTEROLOGY, 1985, 88 (05) : 1334 - 1334
  • [18] A patient with stress-related onset and exacerbations of Graves disease
    Vita, Roberto
    Lapa, Daniela
    Vita, Giuseppe
    Trimarchi, Francesco
    Benvenga, Salvatore
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2009, 5 (01): : 55 - 61
  • [19] A patient with stress-related onset and exacerbations of Graves disease
    Roberto Vita
    Daniela Lapa
    Giuseppe Vita
    Francesco Trimarchi
    Salvatore Benvenga
    Nature Clinical Practice Endocrinology & Metabolism, 2009, 5 : 55 - 61
  • [20] Stress-related Mucosal Disease in the Intensive Care Unit An Update on Prophylaxis
    Sesler, Jefferson M.
    AACN ADVANCED CRITICAL CARE, 2007, 18 (02) : 119 - 126